Tamiles Daiane Borges Santana
Research Subjects
Tamiles Daiane Borges Santana has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Bianca Maria de Jesus1 shared publication
- Bianca Oliveira Souza
Universidade Estadual do Sudoeste da Bahia
1 shared publication - Fernanda Lobo de Lima1 shared publication
- Gisele da Silveira Lemos1 shared publication
- Laiz Freire Lima
Southwest Bahia State University
1 shared publication - Lucas Brasileiro Lemos
Universidade Estadual do Sudoeste da Bahia
1 shared publication
Latest Publications
- Open Access
- 1 July 2025
- Published by Brazilian Journals in Contribuciones A Las Ciencias Sociales
- Vol. 18 (7) , e19714
Prevalence of the use of potentially inappropriate medications for elderly people undergoing hemodialysis and association with the fatigue scale
Patients with chronic kidney disease (CKD) tend to experience gradual damage to their muscle structure, leading to fatigue, a common symptom in individuals on hemodialysis. Furthermore, the use of potentially inappropriate medications (PIM) by older adults can cause weight loss, fatigue, falls, and even death. In this context, this article evaluated the prevalence of PIM use for elderly people with CKD on hemodialysis and its association with the fatigue scale. Cross-sectional, descriptive, and analytical epidemiological study, in which medical records were evaluated and interviews were conducted with elderly patients (≥60 years old) on hemodialysis, from a center for kidney diseases. Sociodemographic and clinical variables, lifestyle, medication use, and fatigue severity scale were analyzed. The categorization of the PIM was carried out according to the Beers Criteria, 2019. The association between the dependent variable and the independent variables was performed through crude analysis, using the binary logistic regression model, with 95% confidence intervals and a significance level of 5%. There was a mean age of 70.19 ± 8.04 years, 61.4% of male patients, and 78.9% with comorbidities. Polypharmacy was used by 93.0% of the patients, with a prevalence of PIM use of 87.7% (mean 3.74 ± 3.50). There was an association between the number of PIMs used with polypharmacy and the fatigue scale. These findings show the need for measures aimed at the safe and rational use of medicines in this population, which can reduce the use of PIMs and their risks, with the active presence of the clinical pharmacist.
- 1 July 2025
- Published by Brazilian Journals in Contribuciones A Las Ciencias Sociales
- Vol. 18 (7) , e19714
Open AccessPrevalence of the use of potentially inappropriate medications for elderly people undergoing hemodialysis and association with the fatigue scale
Patients with chronic kidney disease (CKD) tend to experience gradual damage to their muscle structure, leading to fatigue, a common symptom in individuals on hemodialysis. Furthermore, the use of potentially inappropriate medications (PIM) by older adults can cause weight loss, fatigue, falls, and even death. In this context, this article evaluated the prevalence of PIM use for elderly people with CKD on hemodialysis and its association with the fatigue scale. Cross-sectional, descriptive, and analytical epidemiological study, in which medical records were evaluated and interviews were conducted with elderly patients (≥60 years old) on hemodialysis, from a center for kidney diseases. Sociodemographic and clinical variables, lifestyle, medication use, and fatigue severity scale were analyzed. The categorization of the PIM was carried out according to the Beers Criteria, 2019. The association between the dependent variable and the independent variables was performed through crude analysis, using the binary logistic regression model, with 95% confidence intervals and a significance level of 5%. There was a mean age of 70.19 ± 8.04 years, 61.4% of male patients, and 78.9% with comorbidities. Polypharmacy was used by 93.0% of the patients, with a prevalence of PIM use of 87.7% (mean 3.74 ± 3.50). There was an association between the number of PIMs used with polypharmacy and the fatigue scale. These findings show the need for measures aimed at the safe and rational use of medicines in this population, which can reduce the use of PIMs and their risks, with the active presence of the clinical pharmacist.